Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-893-9 | CAS number: 75-71-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: oral
Administrative data
- Endpoint:
- chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- Limited details available on results
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Reference
- Endpoint:
- three-generation reproductive toxicity
- Remarks:
- based on test type
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Not specified
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- The primary report was not available for review but the data has been reviewed by the World Health Organisation (WHO) experts who have agreed that no effects or dominant lethality was found at either dose level tested.
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- In a three-generation, oral gavage study in rats using CFC-12 (in corn oil) at average doses of 15 and 150 mg/kg per day. Limited details available but the data has been reviewed by the World Health Organisation (WHO) experts.
- GLP compliance:
- not specified
- Remarks:
- likely pre-dates the GLP standards
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on species / strain selection:
- Charles River CD
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Not specified
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- In a three-generation, oral gavage study in rats using CFC-12 (in corn oil) at average doses of 15 and 150 mg/kg per day
- Details on mating procedure:
- Not specified
- Analytical verification of doses or concentrations:
- not specified
- Details on analytical verification of doses or concentrations:
- Not specified
- Duration of treatment / exposure:
- Not specified
- Frequency of treatment:
- Not specified
- Details on study schedule:
- Not specified
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Dose / conc.:
- 15 mg/kg bw/day (nominal)
- Dose / conc.:
- 150 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 50 /sex/dose
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- Male and female rats were given Freon 12 in doses of 15 or 150 mg/kg by intubation. The rats were then bred and evaluated for fertility, corpora lutea, implantation sites, resorption sites, and number of live fetuses per litter.
Groups of 50 males and 50 females of the F1a generation remained in the test for 2 years, with an interim killing at 1 year.
Animals received CFC-12 in corn oil or corn oil alone daily by gavage for 6 weeks, and 5 times/week thereafter.
Dominant Lethal assay, part of a reproductive toxicity study:
The F0 animals of the reproduction study were mated to initiate an F1b litter. Animals were treated with the test substance gavage until pregnancies were terminated in mid-term to give a dominant lethal assay - Positive control:
- Not specified (not required)
- Parental animals: Observations and examinations:
- Not specified
- Oestrous cyclicity (parental animals):
- Not specified
- Sperm parameters (parental animals):
- Not specified
- Litter observations:
- Not specified
- Postmortem examinations (parental animals):
- Not specified
- Postmortem examinations (offspring):
- Not specified
- Statistics:
- Not specified
- Reproductive indices:
- Fertility, corpora lutea, implantation sites, resorption sites, and number of live fetuses per litter.
- Offspring viability indices:
- Number of live fetuses per litter.
- Clinical signs:
- not specified
- Mortality:
- not specified
- Body weight and weight changes:
- not specified
- Food consumption and compound intake (if feeding study):
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Histopathological findings: non-neoplastic:
- not specified
- Other effects:
- not specified
- Reproductive function: oestrous cycle:
- not specified
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- no effects observed
- Description (incidence and severity):
- No effects on fertility index (percentage of matings resulting in pregnancy), no effects on gestation index (% of pregnancies resulting in birth of liver litters).
- Key result
- Dose descriptor:
- NOEL
- Effect level:
- > 150 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Remarks:
- (limited details available)
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- No overt signs of toxicity.
- Mortality:
- mortality observed, non-treatment-related
- Description (incidence):
- no significant differences between treated and control groups in survival and post-natal survival (survival after 4 days or 21 days)
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- in F1a parental generation (treatment started at 6 weeks of age): Body weight gain was depressed in the high-dose groups, particularly among the females.
- Food efficiency:
- effects observed, treatment-related
- Description (incidence and severity):
- Slight decline in food efficiency in high dose females, compared to controls
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
- Reproductive function: oestrous cycle:
- not specified
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- no effects observed
- Description (incidence and severity):
- No effects reported on fertility index of the second parental generation
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- > 150 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Remarks:
- (limited details available)
- Key result
- Critical effects observed:
- no
- Clinical signs:
- not specified
- Description (incidence and severity):
- No effects on viability index (percentage of rats born that survived four days)
No effects on lactation index (percentage of rats alive at 4 days that survived to be weaned at 21 days) - Body weight and weight changes:
- not specified
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- not specified
- Histopathological findings:
- not specified
- Other effects:
- no effects observed
- Description (incidence and severity):
- No dominant lethality was found at either dose level, indicating no chromosomal damage to germ cells.
- Behaviour (functional findings):
- not specified
- Key result
- Dose descriptor:
- NOEC
- Generation:
- F1
- Effect level:
- >= 150 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Remarks:
- No effects reported on the reproductive parameters of the F1 generation and no effects on postnatal survival
- Key result
- Critical effects observed:
- no
- Key result
- Reproductive effects observed:
- no
- Conclusions:
- No dominant lethality was found at either dose level.
The substance is not considered to be classified for fertility effects. - Executive summary:
In a 3-generation oral study using CFC12 (in corn oil) at average doses of 15 and 150 mg/kg per day, Sherman (1974) found no adverse effects in reproductive capability as measured by the fertility index, gestation index, viability index and lactation index. No classification is applicable.
Data source
Referenceopen allclose all
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 974
- Reference Type:
- review article or handbook
- Title:
- MISCELLANEOUS FOOD ADDITIVES - DICHLORODIFLUOROMETHANE
- Author:
- Joint FAO/WHO Expert Committee on Food Additives
- Year:
- 1 975
- Bibliographic source:
- JECFA Toxicological evaluation of some food colours, thickening agents, and certain other substances; WHO FOOD ADDITIVES SERIES NO. 8
Materials and methods
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on species / strain selection:
- Charles River CD
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 2 years
- Frequency of treatment:
- Daily
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Dose / conc.:
- 15 mg/kg bw/day (nominal)
- Dose / conc.:
- 150 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 50
- Control animals:
- yes
Results and discussion
Results of examinations
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- Slight body weight reduction
Effect levels
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- >= 150 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- body weight and weight gain
- Remarks on result:
- not determinable due to absence of adverse toxic effects
Applicant's summary and conclusion
- Conclusions:
- No adverse effects were observed in a 2-year chronic study in rats administered 15 or 150 mg/kg/day by gavage.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.